Celcuity Inc. is a biotechnology company that develops diagnostic tests to optimize cancer treatment. The company’s pioneering approach leverages technology to identify specific cell signaling abnormalities that can guide treatment decisions, potentially improving patient outcomes. With a focus on precision medicine, Celcuity’s innovative products have the potential to revolutionize cancer care.